104 related articles for article (PubMed ID: 6652823)
1. Studies on sustained-release dosage forms. I. Preparation and bioavailability of indomethacin suppositories.
Umeda T; Matsuzawa A; Yokoyama T; Kuroda K; Kuroda T
Chem Pharm Bull (Tokyo); 1983 Aug; 31(8):2793-8. PubMed ID: 6652823
[No Abstract] [Full Text] [Related]
2. Preparation of sustained-release suppositories of indomethacin using a solid dispersion system and evaluation of bioavailability in rabbits.
Ohnishi N; Yokoyama T; Umeda T; Kiyohara Y; Kuroda T; Kita Y; Kuroda K
Chem Pharm Bull (Tokyo); 1986 Jul; 34(7):2999-3004. PubMed ID: 3769103
[No Abstract] [Full Text] [Related]
3. Preparation of sustained-release suppositories containing microencapsulated indomethacin and bioavailability of indomethacin in rabbits.
Nakajima T; Takashima Y; Iida K; Mitsuta H; Furuya A; Koishi M
Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4249-54. PubMed ID: 3435949
[No Abstract] [Full Text] [Related]
4. Studies on sustained-release dosage forms. II. Pharmacokinetics after rectal administration of indomethacin suppositories in rabbits.
Kuroda T; Yokoyama T; Umeda T; Matsuzawa A; Kuroda K; Asada S
Chem Pharm Bull (Tokyo); 1983 Sep; 31(9):3319-25. PubMed ID: 6667541
[No Abstract] [Full Text] [Related]
5. Effect of the molecular weight of polyethylene glycol on the bioavailability of indomethacin sustained-release suppositories prepared with solid dispersions.
Ohnishi N; Kiyohara Y; Kita Y; Kuroda K; Yokoyama T
Chem Pharm Bull (Tokyo); 1987 Aug; 35(8):3511-5. PubMed ID: 3427728
[No Abstract] [Full Text] [Related]
6. Studies of pharmacokinetics of indomethacin in man under consideration of bioavailability.
Hippius M; Reinicke C
Agents Actions Suppl; 1982; 10():109-17. PubMed ID: 6956211
[No Abstract] [Full Text] [Related]
7. Medicament release from suppository bases I: Physicochemical characteristics and bioavailability of indomethacin in rabbits.
Vidras NJ; Reid VE; Bohidar NR; Plakogiannis FM
J Pharm Sci; 1982 Aug; 71(8):945-9. PubMed ID: 7120104
[TBL] [Abstract][Full Text] [Related]
8. Study on absorption of indomethacin from sustained-release suppositories containing hydrogenated soybean lecithin in rabbits.
Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3145-7. PubMed ID: 2632063
[TBL] [Abstract][Full Text] [Related]
9. Studies on sustained-release dosage forms. III. Preparation of nifedipine suppositories and bioavailability in rabbits.
Umeda T; Yokoyama T; Ohnishi N; Kuroda T; Kita Y; Kuroda K; Asada S
Chem Pharm Bull (Tokyo); 1985 Sep; 33(9):3953-9. PubMed ID: 4092295
[No Abstract] [Full Text] [Related]
10. [Pharmaceutical evaluation of a hollow type suppository. III. Effect of macrogol 300 on the bioavailability of indomethacin in rabbits].
Watanabe Y; Tone Y; Suzuki M; Matsumoto M
Yakugaku Zasshi; 1985 Mar; 105(3):284-8. PubMed ID: 4032233
[No Abstract] [Full Text] [Related]
11. Indomethacin sustained-release suppositories containing sugar ester.
Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
Chem Pharm Bull (Tokyo); 1990 Apr; 38(4):1027-31. PubMed ID: 2379274
[TBL] [Abstract][Full Text] [Related]
12. Indomethacin sustained-release suppositories containing sugar ester in polyethylene glycol base.
Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1680-3. PubMed ID: 2208382
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of indomethacin sustained-release suppositories using a hydroxypropylmethylcellulose acetate succinate-polyethylene glycol 2000 solid matrix.
Ohnishi N; Kiyohara Y; Kita Y; Kuroda K; Yokoyama T
Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3935-9. PubMed ID: 3435990
[No Abstract] [Full Text] [Related]
14. Sustained release indomethacin: a double blind comparison with indomethacin suppositories.
Iversen O; Fowles M; Vlieg M; Smidt N; Wigley R
N Z Med J; 1981 Apr; 93(682):261-2. PubMed ID: 7019782
[TBL] [Abstract][Full Text] [Related]
15. [Studies on the bioavailability of sustained-release indomethacin capsules].
Li D; Yang XY; Wang JP; Wang YM; Shan J; Zhang HL; Bai YZ; Tao XH; Mo SY
Yao Xue Xue Bao; 1985 May; 20(5):387-91. PubMed ID: 4083026
[No Abstract] [Full Text] [Related]
16. Preparation and in vitro evaluation of sustained-release suppositories containing microencapsulated indomethacin.
Nakajima T; Takashima Y; Iida K; Mitsuta H; Koishi M
Chem Pharm Bull (Tokyo); 1987 Mar; 35(3):1201-6. PubMed ID: 3607943
[No Abstract] [Full Text] [Related]
17. Evaluation of indomethacin sustained-release suppositories prepared with a methacrylic acid-methacrylic acid methyl ester copolymer-polyethylene glycol 2000 solid matrix.
Ohnishi N; Yokoyama T; Kiyohara Y; Okumura K; Kuroda K
Chem Pharm Bull (Tokyo); 1988 Jan; 36(1):430-4. PubMed ID: 3378304
[No Abstract] [Full Text] [Related]
18. Bioavailability of indomethacin after intramuscular injection and rectal administration of solution and suppositories.
Jensen KM; Grenabo L
Acta Pharmacol Toxicol (Copenh); 1985 Nov; 57(5):322-7. PubMed ID: 4090993
[TBL] [Abstract][Full Text] [Related]
19. Application of curdlan to controlled drug delivery. III. Drug release from sustained release suppositories in vitro.
Kanke M; Tanabe E; Katayama H; Koda Y; Yoshitomi H
Biol Pharm Bull; 1995 Aug; 18(8):1154-8. PubMed ID: 8535416
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of new indomethacin dosage forms.
Waller ES
Pharmacotherapy; 1983; 3(6):324-33. PubMed ID: 6361702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
